Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Market Segment This study forecasts revenue at global, regional, and country levels from 2022 to 2032
It applies to most brand-name pharmaceuticals
Because of their glucose lowering effects, therapies that enhance incretin actions through inhibiting degradation of endogenous incretins or through activation of the GLP-1 receptor are now in use for the treatment of type 2 diabetes
Billing problems appear occasionally
US$ 26.95
US$ 29.56
US$ 23.16
US$ 22.94
US$ 23.50
US$ 28.82
